Clinical Trials Directory

Trials / Completed

CompletedNCT02621554

Impact of Resveratrol on Brain Function and Structure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Max Planck Institute for Human Cognitive and Brain Sciences · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

The study will investigate whether resveratrol could provide positive effects on memory and brain structures and functions in healthy elderly participants.

Detailed description

Cell and animal studies postulated various beneficial effects of resveratrol, ranging from a reduction of inflammatory processes and the treatment of cancer to the prevention of cardiovascular diseases and stroke. With regard to cognitive decline, rodent models for Alzheimer's disease (AD) showed improved learning and decelerated hippocampal neurodegeneration after intake of resveratrol. Animal and first human studies provided evidence that resveratrol might serve as an easy, cost-effective option to develop novel prevention and treatment strategies against age-associated cognitive decline. To test this hypothesis, the researchers study general brain structure and function on healthy older individuals (\> 60years old).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTresveratrol supplementation6 months of resveratrol supplementation
DIETARY_SUPPLEMENTPlacebo6 months of placebo intake

Timeline

Start date
2016-04-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2015-12-03
Last updated
2017-02-08

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02621554. Inclusion in this directory is not an endorsement.